Skip to main content
J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
India flag India · Delayed Price · Currency is INR
1,801.40
+49.10 (2.80%)
Jun 27, 2025, 3:29 PM IST

NSE:JBCHEPHARM Revenue

In the fiscal year ending March 31, 2025, J. B. Chemicals & Pharmaceuticals had annual revenue of 39.18B INR with 12.45% growth. J. B. Chemicals & Pharmaceuticals had revenue of 9.49B in the quarter ending March 31, 2025, with 10.18% growth.

Revenue
39.18B
Revenue Growth
+12.45%
P/S Ratio
7.16
Revenue / Employee
7.38M
Employees
5,311
Market Cap
280.45B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202539.18B4.34B12.45%
Mar 31, 202434.84B3.35B10.63%
Mar 31, 202331.49B7.25B29.91%
Mar 31, 202224.24B3.82B18.69%
Mar 31, 202120.43B2.68B15.09%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sun Pharmaceutical Industries 525.78B
Divi's Laboratories 93.60B
Cipla 272.67B
Apollo Hospitals Enterprise 217.94B
Zydus Lifesciences 232.42B
Mankind Pharma 122.07B
Aurobindo Pharma 317.24B
Fortis Healthcare 77.83B
Revenue Rankings

J. B. Chemicals & Pharmaceuticals News

More News